Literature DB >> 22829422

A comparison of estimators to evaluate the discriminatory power of time-to-event models.

Matthias Schmid1, Sergej Potapov.   

Abstract

Discrimination measures for continuous time-to-event outcomes have become an important tool in medical decision making. The idea behind discrimination measures is to evaluate the performance of a prediction model by measuring its ability to distinguish between observations having an event and those having no event. Researchers proposed a variety of approaches to estimate discrimination measures from a set of right-censored data. These approaches rely on different regularity assumptions that are needed to ensure consistency of the respective estimators. Typical examples of regularity assumptions include the proportional hazards assumption in Cox regression and the random censoring assumption. Because regularity assumptions are often violated in practice, conducting a sensitivity analysis of the estimators is of considerable interest. The aim of the paper is to analyze and to compare the most popular estimators of discrimination measures for event time outcomes. On the basis of the results of an extensive simulation study and the analysis of molecular data, we investigate the behavior of the estimators in situations where the underlying regularity assumptions do not hold. We show that violations of the regularity assumptions may induce a nonignorable bias and may therefore result in biased medical decision making.
Copyright © 2012 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2012        PMID: 22829422     DOI: 10.1002/sim.5464

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  15 in total

1.  Boomerang: A method for recursive reclassification.

Authors:  Sean M Devlin; Irina Ostrovnaya; Mithat Gönen
Journal:  Biometrics       Date:  2016-01-11       Impact factor: 2.571

2.  A Selective Review on Random Survival Forests for High Dimensional Data.

Authors:  Hong Wang; Gang Li
Journal:  Quant Biosci       Date:  2017

3.  A scoring model for predicting survival following primary tumour resection in stage IV colorectal cancer patients with unresectable metastasis.

Authors:  S R Dorajoo; W J H Tan; S X Koo; W S Tan; M H Chew; C L Tang; H L Wee; C W Yap
Journal:  Int J Colorectal Dis       Date:  2015-10-21       Impact factor: 2.571

4.  Survival Forests with R-Squared Splitting Rules.

Authors:  Hong Wang; Xiaolin Chen; Gang Li
Journal:  J Comput Biol       Date:  2017-12-21       Impact factor: 1.549

5.  Significance of lymph node metastasis in cancer dissemination of head and neck cancer.

Authors:  Jae-Keun Cho; Seung Hyup Hyun; Nayeon Choi; Min-Ji Kim; Timothy P Padera; Joon Young Choi; Han-Sin Jeong
Journal:  Transl Oncol       Date:  2015-04       Impact factor: 4.243

6.  The extension of total gain (TG) statistic in survival models: properties and applications.

Authors:  Babak Choodari-Oskooei; Patrick Royston; Mahesh K B Parmar
Journal:  BMC Med Res Methodol       Date:  2015-07-01       Impact factor: 4.615

7.  Boosting the concordance index for survival data--a unified framework to derive and evaluate biomarker combinations.

Authors:  Andreas Mayr; Matthias Schmid
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

8.  Review and evaluation of performance measures for survival prediction models in external validation settings.

Authors:  M Shafiqur Rahman; Gareth Ambler; Babak Choodari-Oskooei; Rumana Z Omar
Journal:  BMC Med Res Methodol       Date:  2017-04-18       Impact factor: 4.615

9.  A novel nonparametric measure of explained variation for survival data with an easy graphical interpretation.

Authors:  Verena Weiß; Matthias Schmidt; Martin Hellmich
Journal:  Ger Med Sci       Date:  2015-10-29

10.  Boosting the discriminatory power of sparse survival models via optimization of the concordance index and stability selection.

Authors:  Andreas Mayr; Benjamin Hofner; Matthias Schmid
Journal:  BMC Bioinformatics       Date:  2016-07-22       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.